Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
1923535
Knihovny.cz E-zdroje
- MeSH
- ELISA MeSH
- exprese genu MeSH
- geny p53 * MeSH
- imunohistochemie MeSH
- lidé MeSH
- monoklonální protilátky MeSH
- mutace * MeSH
- nádorový supresorový protein p53 analýza genetika MeSH
- nádory genetika patologie MeSH
- protilátky MeSH
- transfekce MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- monoklonální protilátky MeSH
- nádorový supresorový protein p53 MeSH
- protilátky MeSH
Accumulation of the p53 protein was analysed in 212 human malignant lesions. Immunohistochemical staining with new polyclonal (CM-1) and monoclonal antibodies (BP 53-12 and BP53-24) to p53 on methacarn-fixed paraffin sections showed positive staining in 161 (76%). The positive tumours were found across a wide range of human malignancies including breast, colon, stomach, bladder and testis carcinomas, soft-tissue sarcomas and melanomas. The staining was always confined to the malignant lesion. Immunoprecipitation and quantitative ELISA assays established that the positive staining was associated with accumulation of the protein and that the protein was frequently in a mutant conformation. Accumulation of mutant p53 protein is therefore a common feature of human malignant disease.